IL140588A0 - Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents - Google Patents

Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents

Info

Publication number
IL140588A0
IL140588A0 IL14058899A IL14058899A IL140588A0 IL 140588 A0 IL140588 A0 IL 140588A0 IL 14058899 A IL14058899 A IL 14058899A IL 14058899 A IL14058899 A IL 14058899A IL 140588 A0 IL140588 A0 IL 140588A0
Authority
IL
Israel
Prior art keywords
tumours
flavonoids
treatment
intended
therapeutic composition
Prior art date
Application number
IL14058899A
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of IL140588A0 publication Critical patent/IL140588A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL14058899A 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents IL140588A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809058A FR2781153B1 (en) 1998-07-15 1998-07-15 FLAVONOID-BASED THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF TUMORS WITH CYTOTOXIC AGENTS
PCT/FR1999/001714 WO2000003706A1 (en) 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents

Publications (1)

Publication Number Publication Date
IL140588A0 true IL140588A0 (en) 2002-02-10

Family

ID=9528648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14058899A IL140588A0 (en) 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents

Country Status (12)

Country Link
EP (1) EP1096930A1 (en)
JP (1) JP2002520356A (en)
KR (1) KR20020003349A (en)
CN (1) CN1139384C (en)
AU (1) AU4789099A (en)
BR (1) BR9912816A (en)
CA (1) CA2337179A1 (en)
EA (1) EA200100140A1 (en)
FR (1) FR2781153B1 (en)
IL (1) IL140588A0 (en)
WO (1) WO2000003706A1 (en)
ZA (1) ZA200100239B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002069949A2 (en) * 2001-03-06 2002-09-12 Prendergast Patrick T Combination therapy for reduction of toxycity of chemotherapeutic agents
EP1808172A3 (en) * 2002-03-06 2010-05-26 Activephyto Technologies Limited Botanical extract compositions and methods of use
ATE361746T1 (en) * 2002-03-06 2007-06-15 Medical Res And Education Trus BOTANICAL EXTRACT WITH ANTI-CANCER ACTIVITY CONTAINING ISOLIQUIRITIGENIN
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
CN1679539A (en) * 2005-01-20 2005-10-12 吴一心 Synergic medicinal composition for preventing from tumor
WO2006099193A2 (en) * 2005-03-11 2006-09-21 The Regents Of The University Of Michigan Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
GB0808974D0 (en) * 2008-05-16 2008-06-25 Veritron Ltd Plant extract and its therapeutic use
US9808477B2 (en) * 2015-07-29 2017-11-07 Macau University Of Science And Technology Use of nobiletin in cancer treatment
US9808439B2 (en) * 2015-07-29 2017-11-07 Macau University Of Science And Technology Use of tangeretin in cancer treatment
JP6775226B2 (en) * 2016-06-30 2020-10-28 国立大学法人広島大学 Anti-cancer drug action enhancer and anti-cancer drug kit equipped with it
CN106562954A (en) * 2016-11-11 2017-04-19 黄冈师范学院 Application of (demethylated) polymethoxylated flavones and paclitaxel drugs in preparation of drugs for treating non-small cell lung cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (en) * 1982-09-09 1994-03-09 理化学研究所 Anti-cancer drug
JPS5959627A (en) * 1982-09-27 1984-04-05 Tatsuo Miyoshi Carcinostatic agent
JPS60199817A (en) * 1984-03-23 1985-10-09 Rikagaku Kenkyusho Carcinostatic agent
JPS632925A (en) * 1986-06-23 1988-01-07 Nippon Kayaku Co Ltd C-kinase inhibitor and anti-tumor agent
FR2633182B1 (en) * 1988-06-23 1993-07-23 Beljanski Mirko ANTI-CANCER PHARMACEUTICAL COMPOSITION AND METHOD OF USING THE INVENTION
JPH04103529A (en) * 1990-08-24 1992-04-06 Tatsuo Miyoshi Carcinostatic agent
JPH04103532A (en) * 1990-08-24 1992-04-06 Tatsuo Miyoshi Carcinostatic agent
JP2514500B2 (en) * 1991-09-14 1996-07-10 呉羽化学工業株式会社 Multidrug resistance inhibitor and expression inhibitor
EP0642793A4 (en) * 1992-05-11 1995-03-29 Tsumura & Co. Apoptosis inducer.
AU5259296A (en) * 1995-04-07 1996-10-23 Warner-Lambert Company Flavones and coumarins as agents for the treatment of athero sclerosis
DE29719198U1 (en) * 1997-10-29 1998-04-23 Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, 14558 Bergholz-Rehbrücke Flavono / flavonoid preparation

Also Published As

Publication number Publication date
BR9912816A (en) 2001-05-08
FR2781153A1 (en) 2000-01-21
FR2781153B1 (en) 2001-08-03
KR20020003349A (en) 2002-01-12
EP1096930A1 (en) 2001-05-09
ZA200100239B (en) 2002-01-09
CN1313765A (en) 2001-09-19
CA2337179A1 (en) 2000-01-27
CN1139384C (en) 2004-02-25
JP2002520356A (en) 2002-07-09
WO2000003706A1 (en) 2000-01-27
EA200100140A1 (en) 2001-06-25
AU4789099A (en) 2000-02-07

Similar Documents

Publication Publication Date Title
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
HUP0002760A3 (en) Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HK1033278A1 (en) Pharmaceutical preparation for use in anti-asthma therapy.
HUP0200441A3 (en) Tetrahydropyran derivatives and their use as therapeutic agents and process for preparation the compounds
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
IL140588A0 (en) Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents
SI0839532T1 (en) Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
IL140580A0 (en) Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents
HUP0104963A3 (en) Compositions for the treatment of skin diseases
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
AU2002243363A8 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
HK1037517A1 (en) Use of apomorphine in the treatment of premature ejaculation
GB0316026D0 (en) Compositions containing gangliosides for use in the treatment of skin disorders
GB2354944B (en) Skin treatment compositions
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
GB0026923D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
HUP0000495A3 (en) Antiperspirant composition as well as use to cool the skin
HUP0105203A2 (en) S-nitrosothiols as agents for the treatment of circulatory dysfunctions and their use
GB9904252D0 (en) Composition for the treatment of pain
AU3061199A (en) Skin treatment compositions and the use thereof
PL355292A1 (en) Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
AU2001223910A1 (en) Interferon-alpha use in the treatment of ewing's family of tumors